Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H R Stagg

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 25, 2017
Isoniazid-resistant tuberculosis: a cause for concern?H R Stagg, M C Lipman, T D McHugh, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 12, 2016
Treatment regimens for rifampicin-resistant tuberculosis: highlighting a research gapH R Stagg, H-A Hatherell, M C Lipman, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 12, 2013
Active case finding for tuberculosis among high-risk groups in low-incidence countriesD Zenner, J Southern, R van Hest, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 20, 2018
Tuberculosis infection and disease in people living with HIV in countries with low tuberculosis incidenceJ R Winter, A L Adamu, R K Gupta, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 18, 2012
Active case finding for pulmonary tuberculosis using mobile digital chest radiography: an observational studyA Story, R W Aldridge, I Abubakar, et al.
Public Health Action|July 12, 2017
Tuberculosis treatment outcomes among disadvantaged patients in IndiaC Jackson, H R Stagg, A Doshi, et al.
Thorax|June 15, 2016
What are the most efficacious treatment regimens for isoniazid-resistant tuberculosis? A systematic review and network meta-analysisH R Stagg, R J Harris, H-A Hatherell, et al.
BMC Infectious Diseases|January 22, 2021
An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot studyJ Surey, H R Stagg, T A Yates, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 29, 2021
Determinants of non-adherence to anti-TB treatment in high income, low TB incidence settings: a scoping reviewA S K Jones, N Bidad, R Horne, et al.
BMC Infectious Diseases|April 13, 2021
Informing the public health response to COVID-19: a systematic review of risk factors for disease, severity, and mortalityM Flook, C Jackson, E Vasileiou, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 25, 2017
Isoniazid-resistant tuberculosis: a cause for concern?H R Stagg, M C Lipman, T D McHugh, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 12, 2016
Treatment regimens for rifampicin-resistant tuberculosis: highlighting a research gapH R Stagg, H-A Hatherell, M C Lipman, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 12, 2013
Active case finding for tuberculosis among high-risk groups in low-incidence countriesD Zenner, J Southern, R van Hest, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 20, 2018
Tuberculosis infection and disease in people living with HIV in countries with low tuberculosis incidenceJ R Winter, A L Adamu, R K Gupta, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 18, 2012
Active case finding for pulmonary tuberculosis using mobile digital chest radiography: an observational studyA Story, R W Aldridge, I Abubakar, et al.
Public Health Action|July 12, 2017
Tuberculosis treatment outcomes among disadvantaged patients in IndiaC Jackson, H R Stagg, A Doshi, et al.
Thorax|June 15, 2016
What are the most efficacious treatment regimens for isoniazid-resistant tuberculosis? A systematic review and network meta-analysisH R Stagg, R J Harris, H-A Hatherell, et al.
BMC Infectious Diseases|January 22, 2021
An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot studyJ Surey, H R Stagg, T A Yates, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 29, 2021
Determinants of non-adherence to anti-TB treatment in high income, low TB incidence settings: a scoping reviewA S K Jones, N Bidad, R Horne, et al.
BMC Infectious Diseases|April 13, 2021
Informing the public health response to COVID-19: a systematic review of risk factors for disease, severity, and mortalityM Flook, C Jackson, E Vasileiou, et al.
Pageof 2